1) S. Toyokuni, “Oxidative stress as an iceberg in carcinogenesis and cancer biology”, Arch. Biochem. Biophys., 2016, 595, 46-49.
2) S. Toyokuni, F. Ito, K. Yamashita, et al., “Iron and thiol redox signaling in cancer; An exquisite balance to escape ferroptosis”, Free Radic. Biol. Med., 2017, 108, 610-626.
3) S. Toyokuni, “Role of iron in carcinogenesis: Cancer as a ferrotoxic disease”, Cancer Sci., 2009, 100, 9-16.
4) L. Zacharski, B. Chow, P. Howes, et al., “Decreased cancer risk after iron reduction in patients with peripheral arterial disease: Results from a randomized trial”, J. Natl. Cancer Inst., 2008., 100, 996-1002.
5) I. Yanatori, D. R. Richardson, K. Imada, et al., “Irone export through the transporter Ferroportin 1 is modulated by the iron chaperone PCBP2”, J. Biol. Chem., 2016, 291, 17303-17318.
6) H. Gunshin, B. Mackenzie, U. Berger, et al., “Cloning and characterization of a mammalian proton-coupled metal-ion transporter”, Nature, 1997, 388, 482-488.
7) H. A. Woo, H. Z. Chae, S. C. Hwang, et al., “Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation”, Science, 2003, 300, 653-656.
8) H. Sies, “German-Japanese relationships in biochemistry: a personal perspective”, Nagoya J. Med. Sci., 2016, 78, 335-347.
9) S.Toyokuni, “Iron-induced carcinogenesis: the role of redox regulation”, Free Radic. Biol. Med., 1996, 20, 553-566.
10) M. Conrad, J. P. Angeli, P. Vandenabeele, et al., “Regulated necrosis: disease relevance and therapeutic opportunities”, Nat. Rev. Drug Discov., 2016, 15, 348-366.
11) T. Hirayama and H. Nagasawa, “Chemical tools for detecting Fe ions”, J. Clin. Biochem. Nutr., 2017, 60, 39-48.
12) F. Ito, T. Nishiyama, L. Shi, et al. “Contrasting intra-and extracellular distribution of catalytic ferrous iron in ovalbumin-induced peritonitis” Biochem. Biophys. Res. Commun., 2016, 476, 600-606.